DaShenLin Pharmaceutical Group Past Earnings Performance
Past criteria checks 2/6
DaShenLin Pharmaceutical Group has been growing earnings at an average annual rate of 10.5%, while the Consumer Retailing industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 19.4% per year. DaShenLin Pharmaceutical Group's return on equity is 13.7%, and it has net margins of 4.2%.
Key information
10.5%
Earnings growth rate
9.6%
EPS growth rate
| Consumer Retailing Industry Growth | 12.8% |
| Revenue growth rate | 19.4% |
| Return on equity | 13.7% |
| Net Margin | 4.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How DaShenLin Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 25,336 | 1,068 | 7,061 | 79 |
| 31 Dec 23 | 24,531 | 1,166 | 6,808 | 81 |
| 30 Sep 23 | 24,154 | 1,287 | 6,719 | 75 |
| 30 Jun 23 | 23,519 | 1,239 | 6,611 | 80 |
| 31 Mar 23 | 22,518 | 1,148 | 6,433 | 80 |
| 31 Dec 22 | 21,248 | 1,036 | 6,293 | 74 |
| 30 Sep 22 | 19,222 | 896 | 5,923 | 71 |
| 30 Jun 22 | 18,425 | 860 | 5,702 | 56 |
| 31 Mar 22 | 17,377 | 835 | 5,430 | 51 |
| 31 Dec 21 | 16,759 | 791 | 5,198 | 45 |
| 30 Sep 21 | 16,446 | 1,013 | 4,913 | 13 |
| 30 Jun 21 | 15,697 | 1,113 | 4,651 | 10 |
| 31 Mar 21 | 15,280 | 1,122 | 4,411 | 6 |
| 31 Dec 20 | 14,583 | 1,062 | 4,178 | 5 |
| 30 Sep 20 | 13,593 | 1,014 | 3,881 | 0 |
| 30 Jun 20 | 12,829 | 917 | 3,694 | 1 |
| 31 Mar 20 | 11,925 | 799 | 3,562 | 1 |
| 31 Dec 19 | 11,141 | 703 | 3,424 | 0 |
| 30 Sep 19 | 10,601 | 674 | 3,292 | 2 |
| 30 Jun 19 | 10,029 | 624 | 3,169 | 1 |
| 31 Mar 19 | 9,404 | 569 | 3,053 | 1 |
| 31 Dec 18 | 8,859 | 532 | 2,906 | 1 |
| 30 Sep 18 | 8,421 | 522 | 2,710 | 0 |
| 30 Jun 18 | 8,003 | 515 | 2,542 | 0 |
| 31 Mar 18 | 7,718 | 505 | 2,393 | 0 |
| 31 Dec 17 | 7,421 | 475 | 2,275 | 0 |
| 30 Sep 17 | 6,992 | 462 | 2,152 | 0 |
| 30 Jun 17 | 6,824 | 458 | 2,052 | 0 |
| 31 Mar 17 | 6,545 | 433 | 1,960 | 0 |
| 31 Dec 16 | 6,274 | 430 | 1,867 | 0 |
| 30 Jun 16 | 5,681 | 427 | 1,665 | 0 |
| 31 Mar 16 | 5,464 | 415 | 1,584 | 0 |
| 31 Dec 15 | 5,265 | 395 | 1,541 | 0 |
| 31 Dec 14 | 4,545 | 266 | 1,341 | 0 |
| 31 Dec 13 | 3,707 | 197 | 1,071 | 0 |
Quality Earnings: 603233 has high quality earnings.
Growing Profit Margin: 603233's current net profit margins (4.2%) are lower than last year (5.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603233's earnings have grown by 10.5% per year over the past 5 years.
Accelerating Growth: 603233's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 603233 had negative earnings growth (-7%) over the past year, making it difficult to compare to the Consumer Retailing industry average (-4.4%).
Return on Equity
High ROE: 603233's Return on Equity (13.7%) is considered low.